Millennium Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-672
| Closed | -$7.12K | – | 6649 |
|
|
2023
Q4 | $7.12K | Buy |
+672
| New | +$8.09K | ﹤0.01% | 5778 |
|
|
2023
Q3 | – | Sell |
-411
| Closed | -$31.5K | – | 6553 |
|
|
2023
Q2 | $31.5K | Sell |
411
-3,088
| -88% | -$250K | ﹤0.01% | 5567 |
|
|
2023
Q1 | $331K | Buy |
3,499
+957
| +38% | +$91.1K | ﹤0.01% | 4845 |
|
|
2022
Q4 | $247K | Buy |
+2,542
| New | +$368K | ﹤0.01% | 5211 |
|
|
2022
Q3 | – | Sell |
-14,465
| Closed | -$2.69M | – | 7486 |
|
|
2022
Q2 | $2.69M | Buy |
14,465
+10,852
| +300% | +$1.04M | ﹤0.01% | 3403 |
|
|
2022
Q1 | $354K | Sell |
3,613
-8,994
| -71% | -$1.15M | ﹤0.01% | 5408 |
|
|
2021
Q4 | $2.06M | Buy |
12,607
+6,068
| +93% | +$1.33M | ﹤0.01% | 3754 |
|
|
2021
Q3 | $1.78M | Buy |
6,539
+4,078
| +166% | +$1.25M | ﹤0.01% | 4054 |
|
|
2021
Q2 | $975K | Buy |
+2,461
| New | +$1.15M | ﹤0.01% | 4686 |
|
|
2021
Q1 | – | Sell |
-5,489
| Closed | -$2.08M | – | 6500 |
|
|
2020
Q4 | $2.08M | Buy |
5,489
+558
| +11% | +$222K | ﹤0.01% | 3206 |
|
|
2020
Q3 | $1.86K | Sell |
4,931
-3,935
| -44% | -$1.74M | ﹤0.01% | 2651 |
|
|
2020
Q2 | $4.36M | Buy |
8,866
+8,648
| +3,967% | +$3.86M | 0.01% | 1911 |
|
|
2020
Q1 | $80K | Sell |
218
-9,165
| -98% | -$4.74M | ﹤0.01% | 3597 |
|
|
2019
Q4 | $6.64M | Buy |
9,383
+7,716
| +463% | +$5.31M | 0.01% | 1695 |
|
|
2019
Q3 | $1.07M | Sell |
1,667
-660
| -28% | -$524K | ﹤0.01% | 2811 |
|
|
2019
Q2 | $2.04M | Buy |
+2,327
| New | +$1.6M | ﹤0.01% | 2390 |
|
|
2018
Q4 | – | Sell |
-72
| Closed | -$34K | – | 4163 |
|
|
2018
Q3 | $34K | Buy |
+72
| New | +$30.9K | ﹤0.01% | 3814 |
|
|
2018
Q1 | – | Sell |
-71
| Closed | -$44K | – | 4070 |
|
|
2017
Q4 | $44K | Sell |
71
-1,173
| -94% | -$843K | ﹤0.01% | 3725 |
|
|
2017
Q3 | $1.15M | Sell |
1,244
-218
| -15% | -$194K | ﹤0.01% | 2443 |
|
|
2017
Q2 | $1.36M | Buy |
1,462
+1,372
| +1,524% | +$1.34M | ﹤0.01% | 2298 |
|
|
2017
Q1 | $85K | Sell |
90
-814
| -90% | -$758K | ﹤0.01% | 3342 |
|
|
2016
Q4 | $726K | Buy |
904
+814
| +904% | +$734K | ﹤0.01% | 2429 |
|
|
2016
Q3 | $76K | Sell |
90
-1,760
| -95% | -$1.41M | ﹤0.01% | 3156 |
|
|
2016
Q2 | $1.52M | Buy |
+1,850
| New | +$2.01M | ﹤0.01% | 1932 |
|
|
2016
Q1 | – | Sell |
-148
| Closed | -$184K | – | 3645 |
|
|
2015
Q4 | $184K | Sell |
148
-887
| -86% | -$1.47M | ﹤0.01% | 3120 |
|
|
2015
Q3 | $1.4M | Buy |
+1,035
| New | +$1.71M | ﹤0.01% | 2114 |
|
|
2015
Q1 | – | Sell |
-76
| Closed | -$58K | – | 4079 |
|
|
2014
Q4 | $58K | Sell |
76
-9
| -11% | -$4.78K | ﹤0.01% | 3818 |
|
|
2014
Q3 | $34K | Buy |
+85
| New | +$41K | ﹤0.01% | 3619 |
|
|
2013
Q4 | – | Sell |
-472
| Closed | -$279K | – | 3770 |
|
|
2013
Q3 | $279K | Buy |
+472
| New | +$213K | ﹤0.01% | 2908 |
|
Other funds holding TCRT
MP
CB
ACM
Millennium Management's TCRT Position: Q1 2024 in Review
Millennium Management sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 672 shares — an estimated $7.12K sold.
Millennium Management first reported a position in TCRT in Q3 2013 and held it in 29 quarters. The position peaked at $6.64M in Q4 2019. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Millennium Management reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 672 Alaunos Therapeutics shares in Q1 2024, an estimated $7.12K.
- Millennium Management first reported a position in Alaunos Therapeutics in Q3 2013 and held it in 29 quarters.
- Millennium Management's Alaunos Therapeutics position peaked at $6.64M in Q4 2019.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.